RNAMolecular BiologyPeer-reviewed journal article
A dual role for the RNA helicase DHX34 in NMDand pre-mRNA splicing and its function inhematopoietic differentiation
Nele HugiD, Stuart AitkeniD, Dáša LongmaniD, Michaela RaabiD, Hannah ArmesiD, Abigail R. ManniD, Ana Rio‐MachíniD, Jude FitzgibboniD, Kevin Rouault‐PierreiD, Javier F. CáceresiD
Abstract
The DExD/H-box RNA helicase DHX34 is a Nonsense-mediated decay (NMD) factor that together with core NMD factors co-regulates NMD targets in nematodes and in vertebrates. Here, we show that DHX34 is also associated with the human spliceosomal catalytic C complex. Mapping of DHX34 endogenous binding sites using Cross-Linking Immunoprecipitation (CLIP) revealed that DHX34 is preferentially associated with pre-mRNAs and locates at exon-intron boundaries. Accordingly, we observed that DHX34 regulates a large number of alternative splicing (AS) events in mammalian cells in culture, establishing a dual role for DHX34 in both NMD and pre-mRNA splicing. We previously showed that germline DHX34 mutations associated to familial Myelodysplasia (MDS)/Acute Myeloid Leukemia (AML) predisposition abrogate its activity in NMD. Interestingly, we observe now that DHX34 regulates the splicing of pre-mRNAs that have been linked to AML/MDS predisposition. This is consistent with silencing experiments in hematopoietic stem/progenitor cells (HSPCs) showing that loss of DHX34 results in differentiation blockade of both erythroid and myeloid lineages, which is a hallmark of AML development. Altogether, these data unveil new cellular functions of DHX34 and suggests that alterations in the levels and/or activity of DHX34 could contribute to human disease.
- organism: human
- assay: multiome
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 18
- FWCI
- 0.98
- Field percentile
- top 28%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Somatic DDX41 mutations confer neomorphic splicing activity in the pathogenesis of myelodysplastic neoplasms
Rasika Venkataraman, Noemi Puccio, … Stanley Chun-Wei Lee·bioRxiv·Sep 24, 2026
- Regulation of RUVBL1-RUVBL2 AAA-ATPases by the nonsense-mediated mRNA decay factor DHX34, as evidenced by Cryo-EM
O. Llorca, A. Lopez-Perrote, … J. F. Caceres·bioRxiv·Sep 28, 2020
- Splicing quality control mediated by DHX15 and itsG-patch activator, SUGP1
Qing Feng, Keegan S. Krick, … Christopher B. Burge·Cell ReportsPeer-reviewed·Oct 1, 2023
- The tumour suppressor RBM5 activates the helicase DHX15 to regulate splicing
Z. Hong Zhou, Shiheng Liu, … Andrey Damianov·bioRxiv·Mar 27, 2026
- CDK8 is a critical effector of cell fate dysregulation in SF3B1-mutant MDS
Elizabeth A. Bonner, Tun‐Yun Hsueh, … Stanley Chun-Wei Lee·bioRxiv·Aug 14, 2025
- A Model for DHX15 Mediated Disassembly of A-Complex Spliceosomes
Hannah M. Maul-Newby, Angela N. Amorello, … Melissa S. Jurica·RNAPeer-reviewed·Jan 19, 2022